1. CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas. (15th April 2015) Authors: Wobser, M.; Roth, S.; Reinartz, T.; Rosenwald, A.; Goebeler, M.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas. (15th April 2015) Authors: Wobser, M.; Roth, S.; Reinartz, T.; Rosenwald, A.; Goebeler, M.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CD68 expression is a discriminative feature of indolent cutaneous CD8‐positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8‐positive cutaneous lymphomas. (1st June 2015) Authors: Wobser, M.; Roth, S.; Reinartz, T.; Rosenwald, A.; Goebeler, M.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 172:Number 6(2015:Jun.) Page Start: 1573 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Genetic alterations in CD30-positive lymphoproliferations. (2019) Authors: Maurus, K.; Roth, S.; Appenzeller, S.; Goebeler, M.; Rosenwald, A.; Geissinger, E.; Wobser, M. Journal: European journal of cancer Issue: Volume 119(2019)Supplement 1 Page Start: S14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma. (11th October 2015) Authors: Brenner, I.; Roth, S.; Flossbach, L.; Wobser, M.; Rosenwald, A.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 173:Number 6(2015:Dec.) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lack of myeloid differentiation primary response protein MyD88 L265P mutation in primary cutaneous marginal zone lymphoma. (1st December 2015) Authors: Brenner, I.; Roth, S.; Flossbach, L.; Wobser, M.; Rosenwald, A.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 173:Number 6(2015:Dec.) Page Start: 1527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal‐zone lymphoma with a nonclass‐switched immunoglobulin M immunophenotype. (1st August 2017) Authors: Wobser, M.; Maurus, K.; Roth, S.; Appenzeller, S.; Weyandt, G.; Goebeler, M.; Rosenwald, A.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myeloid differentiation primary response 88 mutations in a distinct type of cutaneous marginal‐zone lymphoma with a nonclass‐switched immunoglobulin M immunophenotype. (31st July 2017) Authors: Wobser, M.; Maurus, K.; Roth, S.; Appenzeller, S.; Weyandt, G.; Goebeler, M.; Rosenwald, A.; Geissinger, E. Journal: British journal of dermatology Issue: Volume 177:Number 2(2017) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. (1st September 2020) Authors: Weber, J.; Glutsch, V.; Geissinger, E.; Haug, L.; Lock, J.F.; Schneider, F.; Kneitz, H.; Goebeler, M.; Schilling, B.; Gesierich, A. Journal: British journal of dermatology Issue: Volume 183:Number 3(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Primary cutaneous peripheral T‐cell lymphoma, not otherwise specified: results of a multicentre European Organization for Research and Treatment of Cancer (EORTC) cutaneous lymphoma taskforce study on the clinico‐pathological and prognostic features. (22nd December 2020) Authors: Kempf, W.; Mitteldorf, C.; Battistella, M.; Willemze, R.; Cerroni, L.; Santucci, M.; Geissinger, E.; Jansen, P.; Vermeer, M.H.; Marschalko, M.; Papadavid, E.; Piris, M.A.; Ortiz‐Romero, P.L.; Novelli, M.; Paulli, M.; Quaglino, P.; Ranki, A.; Rodríguez Peralto, J.L.; Wobser, M.; Auschra, B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 3(2021) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗